Additionally, several studies demonstrated the utility of EP4 as a promising therapeutic target in cardiac diseases including not only ischemic heart disease but also inflammatory heart disease [34] and cardiac hypertrophy [35]. The gene discussed is PTGER4; the disease is cardiac hypertrophy.